NEW YORK (GenomeWeb News) — The US federal anti-trust waiting period has passed on Roche’s hostile takeover bid for Ventana Medical Systems, Roche said today.
  
The expiration of the Hart-Scott-Rodino waiting period satisfies one condition of Roche’s offer, under which it would buy all of Ventana’s outstanding shares for $75 in cash per share, or $3 billion.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A team of researchers plans to sample Loch Ness for environmental DNA, according to Newsweek.

US News & World Report writes that genetic testing of lung tumors can help identify treatments for patients.

The New York Times writes about the appearance of mosaicism in healthy people.

In PNAS this week: insecticide resistance patterns Anopheles gambiae mosquito, transcriptome patterns in Pseudomonas aeruginosa during infection, and more.